Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

HPV Test Bests Pap Smear in Studies


Related Encyclopedia
 border=
Abscess
Actinomycosis
Acute Myeloid Leukemia (Adult)
Adenocarcinoma of the Lung and Brain Metastases
More...

Related Healthscout Videos
 border=
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
When's the Next Free Mammogram Day? October 17, 2008!!!
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Abilify
Actonel
Augmentin
Bactroban Cream
More...

Related News Articles
 border=
Iressa as Good as Chemotherapy for Lung Cancer
Latin Women More Likely to Be Unhappy With Breast Cancer Treatment Decisions
Scientists ID Uterine Muscle Switch for Contractions
Long-Term Erythromycin Cut COPD Complications
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

The study included more than 10,000 women between 30 and 69 years old who were randomly assigned to one of the tests. The HPV test detected 94.6 percent of the abnormal growths that can lead to cervical cancer, while the Pap test found only 55.4 percent of these growths. Women who had an abnormal result were referred for further testing. If both Pap and HPV were used together, 100 percent of the abnormal growths were found. The false-positive rate for HPV was only 2.7 percent higher than the rate for Pap smears, according to the study.

"Even though Pap has worked, we have a test that's better than Pap, and in the coming years, we can switch to HPV and possibly screen every three or maybe even every five years and get the same level of protection," said study author Dr. Marie-Helene Mayrand, an assistant professor of obstetrics and gynecology and social and preventive medicine at the University of Montreal. Mayrand was a doctoral candidate at McGill University in Montreal at the time of the study.

The second study, done in Sweden, included more than 12,000 women in their 30s who were randomized to receive either a conventional Pap test alone or an HPV test and a Pap test.

Text Continues Below



The researchers found abnormal cervical changes in 51 percent more women who had both tests than in the Pap group alone. In subsequent screenings, about 40 percent fewer precancerous lesions were found in the women who'd been screened with both tests compared to women who'd had the Pap test alone, which suggests that overdiagnosis from the HPV test is not as big an issue as some experts had feared.

"Adding HPV testing to Pap testing in routine cervical screening gives a longer protection against the severe precursor lesions of cervical cancer compared to just Pap testing," said study co-author Dr. Joakim Dillner, a professor of virology at Lund University and Malmo University Hospital in Malmo, Sweden.

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 10/17/2007

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Joakim Dillner, M.D., Ph.D., professor, virology, Lund University and Malmo University Hospital, Malmo, Sweden; Marie-Helene Mayrand, M.D., assistant professor, obstetrics and gynecology and social and preventive medicine, University of Montreal; Debbie Saslow, Ph.D., director, breast and gynecologic cancer, American Cancer Society, Atlanta; Oct. 18, 2007, New England Journal of Medicine


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.